Category Archives: Myocardial Infarction

Although guidelines permit up to a 30% acute increase in creatinine following initiation of renin angiotensin system inhibitors (RASi), new evidence published in the Clinical Journal of the American Society of Nephrology associates creatinine rises of 10% or more with increased risks for death, cardiovascular events, and end-stage renal disease (ESRD). Continue reading →

What is Ischemic Heart Disease? Ischemic heart disease is caused by an imbalance between the myocardial blood flow and the metabolic demand of the myocardium.Reduction in coronary blood flow is related to progressive atherosclerosis with increasing occlusion of coronary arteries. Blood flow can be further decreased by superimposed events such as vasospasm, thrombosis, or circulatory changes leading to hypoperfusion. Continue reading →

According to the world health organization, cardiovascular disease is the leading cause of death worldwide, as well as in the US. Of those, a large proportion are caused by heart attacks, also known as acute myocardial infarctions, or just myocardial infarctions, sometimes just called MI. The word infarction means that some area of tissue has died due to a lack of blood flow, and therefore a lack of oxygen. Continue reading →

Endogenous cardioprotection, influence of the presence of risk factors: Ischemic preconditioning is a well-described adaptive response in which brief exposure to ischemia markedly enhances the ability of the heart to withstand a subsequent ischemic injury. Moreover, brief cycles of ischemia/reperfusion applied following a longer period of ischemia also confer cardioprotection against the consequences of myocardial ischemia/reperfusion, a phenomenon called ischemic postconditioning. Continue reading →

Overview A heart attack occurs when the flow of blood to the heart is blocked. The blockage is most often a buildup of fat, cholesterol and other substances, which form a plaque in the arteries that feed the heart (coronary arteries) Continue reading →

Acute STEMI (ST Elevation Myocardial Infarction) is the most severe manifestation of coronary artery disease. This chapter deals with the pathophysiology, definitions, criteria and management of patients with acute STEMI. Although ECG changes in acute STEMI have been discussed previously (refer to ECG Changes in Acute Myoardial Infarction), a rehearsal is provided below Continue reading →

Medically reviewed by Drugs.com. Continue reading →

Mar 12, 2019 (Heraldkeeper via COMTEX) -- Global Myocardial Infarction Therapeutics Market report contains all study material about overview, growth, demand and forecast research report in all over the world. This report offers some penetrating overview and solution in the complex world Global Myocardial Infarction Therapeutics industry in global market. This research report categorizes the global Myocardial Infarction Therapeutics market by top players/brands, region, type and end user. Continue reading →

Electrocardiography in suspected myocardial infarction has the main purpose of detecting ischemia or acute coronary injury in emergency department populations coming for symptoms of myocardial infarction (MI). Also, it can distinguish clinically different types of myocardial infarction. Continue reading →

Clinical Relevance of Anterior Myocardial Infarction Anterior STEMI results from occlusion of the left anterior descending artery (LAD). Anterior myocardial infarction carries the worst prognosis of all infarct locations, mostly due to larger infarct size. Continue reading →